Patient-oriented measures for phase 3 studies of tralokinumab for the treatment of atopic dermatitis (ECZTRA 1, 2, and 3)
- Resource Type
- Article
- Source
- In
Annals of Allergy, Asthma & Immunology November 2022 129(5):592-604 - Subject
- Language
- ISSN
- 1081-1206